[Submitted on 16 Mar 2026 (v1), last revised 18 Nov 2026 (this version, v2)]
Abstract:Causal discovery is increasingly applied to healthcare data, where the recovered relationships can encode biased pathways that propagate to downstream prediction. Path-specific fairness analysis, through direct, indirect, and spurious effect decompositions along with fairness-utility ratio assessment allows bias quantification and associated prediction cost. However, existing evaluations of causal discovery under fairness constraints have largely used non-clinical datasets and have not separated the contribution of confounders from that of mediators, leaving open how discovery-algorithm choice propagates through path-specific fairness to the utility trade-off in clinical settings. This work addresses that gap by establishing an expert-elicited causal graph benchmark for the heart failure clinical records dataset and tracing discovery algorithms through composite, per-variable fairness decompositions and fairness-utility ratio. ICA-LiNGAM achieves the lowest structural Hamming distance and highest recall, while GES achieves the highest precision. For path-specific effects, there was a 1.2 percentage-point difference in the mediated effect on ejection fraction on overall causal fairness between the original and discovered graphs. This ultimately led to variations in the fairness-utility ratio highlighting need for fine-grained evaluation. These results indicate that discovery-aware, path-specific fairness evaluation is consequential in clinical settings and warrants inclusion in routine auditing of clinical risk models.
Submission history
From: Nitish Nagesh [view email]
[v1] Mon, 16 Mar 2026 21:19:17 UTC (360 KB)
[v2] Wed, 18 Nov 2026 05:43:50 UTC (12 KB)
